# Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

> **NCT01032694** · — · TERMINATED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Community-Acquired Pneumonia

## Interventions

- **DRUG:** Azithromycin SR
- **DRUG:** Amoxiclav

## Key facts

- **NCT ID:** NCT01032694
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** This study was terminated January 11, 2011 due to low enrollment. This study is not being terminated because of safety or efficacy concerns.
- **Last updated:** 2011-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032694, "Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01032694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*